INTCO Medical's 40.6% revenue jump and capacity expansion to 107 billion gloves signal strong growth in the global disposable glove market

Executive summary: INTCO Medical announced a 40.6% increase in H1 2026 revenue to RMB 6.91 billion and expanded its disposable glove capacity to 107 billion units. The growth and capacity boost reinforce INTCO’s leadership in the glove sector and could influence global PPE supply dynamics and pricing.

Who is involved: INTCO Medical (ticker 300677.SZ), its management, and investors in the disposable glove market.

Likely next: The firm may pursue additional capex to sustain capacity, seek ESG‑linked financing, and face heightened scrutiny of product quality from regulators.

INTCO Medical reported half‑year revenue of RMB 6.91 billion (≈USD 1.03 billion), up 40.6% year‑on‑year, and said it has scaled its disposable glove output to 107 billion pieces, retaining the title of world’s largest glove maker. The figures reflect robust demand for personal protective equipment and the company’s continued investment in production capacity. No contradictory data were presented in the release.

Timeline

2026-08-30 — INTCO Medical rapporteert omzetgroei van 40,6% in de eerste helft van 2026, breidt de grootste wegwerphandschoenencapaciteit ter wereld uit tot 107 miljard stuks (PR Newswire)
2026-08-05 — INTCO Medical distinguée dans le « S&P Global Sustainability Yearbook » (édition chinoise) 2025 pour ses progrès en matière d'ESG (PR Newswire)
2026-08-05 — INTCO Medical es reconocida por sus avances en materia de ESG (PR Newswire)

Analysis — what this means

Likely next events

INTCO Medical aims to reach full 107‑billion‑glove capacity by Q4 2026.
The company may announce a new raw‑material procurement deal in Q1 2027 to support sustained output.
EU market surveillance of glove quality under PPE Regulation (EU) 2016/425 is expected in Q3 2026.
INTCO’s ESG reporting will be updated ahead of the S&P Global Sustainability Yearbook 2026 release in early 2027.

Sectors affected

disposable glove manufacturing
healthcare PPE supply chain
medical device sector

Regulatory implications

EU PPE Regulation (EU) 2016/425 requires ongoing compliance checks on glove sterility and labeling.
China’s Ministry of Industry and Information Technology may introduce stricter waste‑disposal rules for single‑use gloves in 2027.
US FDA could review imported glove sterility standards amid rising import volumes.

Historical parallels

2020 COVID‑19 pandemic sparked a global glove shortage, prompting Top Glove Corp (Malaysia) to add 20 billion units of capacity.
2021 rubber price spikes pressured glove margins, leading to cost‑pass‑through initiatives by Hartalega.
2022 ESG‑linked financing drove sustainable glove lines at Ansell, increasing market share of eco‑friendly products.